Measuring Dabigatran Concentrations Using a Chromogenic Ecarin Clotting Time Assay

Abstract

The chromogenic ECA appears to be an effective approach to determine the amount of dabigatran present. Further insights are necessary to determine how it can be used to reduce thromboembolic or bleeding complications in patients receiving dabigatran.